NASHVILLE, Tenn., July 15, 2019 /PRNewswire/ -- SmileDirectClub, the pioneer of teledentistry and market leader in remote clear aligner therapy, announced

AQUEBOGUE, N.Y., July 15, 2019 /PRNewswire/ -- Altaire Pharmaceuticals, Inc., announces today that it is voluntarily recalling the over the counter (OTC) and prescription (Rx)  drug products and lots, within expiry, it has manufactured and distributed under the Altaire label and trade dress during the time period as indicated below.  As a precautionary mea

AQUEBOGUE, N.Y., July 15, 2019 /PRNewswire/ -- Altaire Pharmaceuticals, Inc., announces today that it is correcting its July 3, 2019 Announcement of a Voluntary Recall for Over-the-Counter (OTC)  drug products and lots, within expiry, sold at Wal-Mart during the time period as indicated in the tables below.  Correc

PHILADELPHIA, July 15, 2019 /PRNewswire/ -- GSK today announced it will begin shipping its quadrivalent influenza vaccines to US healthcare providers and pharmacies for the 2019-20 flu season, immediately following licensing and lot-release approval from the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research.

KELOWNA, BC, July 15, 2019 /PRNewswire/ - Valens GroWorks Corp. (TSXV: VGW) (OTC: VGWCF) (the "Company" or "Valens"), a vertically integrated provider of industry leading extraction products and services; including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredited analytica

BOSTON, July 15, 2019 /PRNewswire/ -- Hundreds of Bostonians today joined The ALS Association to commemorate the fifth anniversary of the ALS Ice Bucket Challenge with its co-founders, Pete Frates (Beverly, Mass.) and Pat Quinn (Yonkers, NY

WARREN, N.J., July 15, 2019 /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive"), a specialty pharmaceutical company focused on developing and commercializing differentiated products based on its proprietary PharmFilm® technology to meet patients' unmet needs and solve therapeutic problems, today announced that it has completed a p

REDWOOD CITY, Calif., July 15, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the Company will release its financial results for the second quarter ended June 30, 2019 after the market closes on

Company Joined by Other Industry Leaders as Part of ISO Cardiac Valves Working GroupNASDAQ, TSX: NVCN VANCOUVER, July 15, 2019 /PRNewswire/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies an

PHILADELPHIA, July 15, 2019 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX, "Aevi") today announced it has entered into an exclusive license agreement with OSI Pharmaceuticals, LLC, an indirect wholly-owned subsidiary of Astellas Pharma Inc. ("Astellas") for the worldwide development and commercialization of Astellas' second generation mTORC1/2 inhibitor, ASP7